The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; none of the 99 sources its claims cite is checked for support yet.
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Open accessAbstract
Background/Aims: The diagnostic criteria for polycystic ovary syndrome (PCOS) in adolescence are controversial, primarily because the diagnostic pathological features used in adult women may be normal pubertal physiological events. Hence, international pediatric and adolescent specialty societies have defined criteria that have sufficient evidence to be used for the diagnosis of PCOS in adolescents. Methods: The literature has been reviewed and evidence graded to address a series of questions regarding the diagnosis of PCOS during adolescence including the following: clinical and biochemical evidence of hyperandrogenism, criteria for oligo-anovulation and polycystic ovary morphology, diagnostic criteria to exclude other causes of hyperandrogenism and amenorrhea, role of insulin resistance, and intervention. Results and Conclusion: Features of PCOS overlap normal pubertal development. Hence, caution should be taken before diagnosing PCOS without longitudinal evaluation. However, treatment may be indicated even in the absence of a definitive diagnosis. While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 99 cited sources checked · 0 supported · 0 flagged
In the paper
“The diagnostic criteria for PCOS in adolescence are controversial, primarily because the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
What the sources say
- Not checked yetcites [18] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“With the exception of one published recommendation, none of the current definitions of PCOS in adolescent or adult women include insulin resistance/hyperinsulinemia as a diagnostic criterion [1, 10-12, 18, 19, 112]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“It is important to realize that about half of otherwise asymptomatic mild hirsutism is not associated with hyperandrogenemia [22,24]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, mild or focal hirsutism may be a sign of hyperandrogenemia in young women when associated with other evidence of PCOS, i.e., menstrual irregularity [29][30][31][32]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [29][30][31][32]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Insulin resistance and hyperinsulinemia are intrinsic to PCOS in adults and adolescents, lean or obese.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The severity of hirsutism does not correlate well with circulating androgen concentrations [26]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [26] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Hyperinsulinemia is believed to exacerbate the hyperandrogenism and the reproductive and metabolic manifestations of PCOS in adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“All adult PCOS criteria consider hirsutism as evidence of clinical hyperandrogenism.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [10][11][12]
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Features of PCOS overlap normal pubertal development.”
- Also stated in: § Introduction · hedged
“the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
What the sources say
- Not checked yetcites [18] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Introduction · hedged
- Probably not a substantial claim. 12
- It may state two separate claims as one. 21
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, insulin resistance and/ or hyperinsulinemia should not be used to diagnose PCOS among adolescent girls.”
- Also stated in: § Recommendations · plain
“Although prevalent among adolescents at risk for PCOS, insulin resistance and hyperinsulinemia should not be utilized as diagnostic criteria (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Also stated in: § Recommendations · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Upper lip scores of 3-4 were found in <3% of Black and White US adolescents, though scores of 1-2 rose in prevalence from 7.3% at <2 years after menarche to 28.2% at >2 years after menarche [40,41]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Even though hirsutism is common among women with hyperandrogenism, the latter can occur in the absence of cutaneous manifestations [2,3]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Biochemical evidence of hyperandrogenism, as indicated by persistent elevation of serum total and/or free testosterone levels and determined in a reliable reference laboratory, provides the clearest support for the presence of hyperandrogenism in an adolescent girl with symptoms of PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“PCOM, variously defined, has been reported with a prevalence of 30-40% (range between 26 and 54%) and has been described in healthy girls [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“weight loss, treatment with metformin, or treatment with rosiglitazone were associated with improved insulin sensitivity and attenuation of hyperandrogenemia in some studies [133][134][135][136][137]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [133][134][135][136][137]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Further, a multifollicular pattern, which is defined by the presence of large follicles distributed throughout the ovary, does not have a relationship with hyperandrogenism, is more common in adolescents, and should not be considered a pathological finding (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“a population-based study from Australia of adolescents considered to have PCOS in which increased free testosterone concentration was the factor most predictive of insulin resistance, while menstrual irregularities and polycystic ovaries were not associated with insulin resistance [127]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [127] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Menstrual irregularity is common among adolescents and is generally the result of anovulatory cycles.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Although morning 17-OHP concentrations (>200 ng/dl) have been reported as being more common in women with CAH (87%), over 20% of women with PCOS had elevated morning 17-OHP values [110]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [110] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Regular cycles (21-45 days) are established by the third year after menarche in approximately 95% of girls, but cycles can remain irregular until the fifth year.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [64][65][66][67]
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Accordingly, the persistence of oligomenorrhea (menstrual cycles longer than 45 days), secondary amenorrhea (absence of cycles for more than 3 months), or primary amenorrhea in girls with complete pubertal development and adult stature suggests the coexistence of androgen excess [71,78]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While comedonal acne is common in adolescent girls, moderate or severe comedonal acne (i.e., 10 or more facial lesions) in early puberty or moderate inflammatory acne through the perimenarcheal years is uncommon (<5% prevalence) [42,43]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moderate to severe hirsutism constitutes clinical evidence of hyperandrogenism (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“The reported prevalence for NCAH is 1 in 1,000 with an increased prevalence in specific ethnic groups [99]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [99] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Legro et al. [69] found that over 90% of adolescent females have 10 or more menstrual cycles per year (average menstrual interval 36.5 days) 3 years after menarche.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [69] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Follow-up of a different group of unselected healthy adolescents for 12 years showed tracking of androgen levels into adulthood; higher levels in adolescence were associated with lower fertility, suggesting evolving PCOS [59]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [59] source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Follicle counts should not be utilized to define PCOM in adolescents (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No compelling criteria to define PCOM have been established for adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: No compelling criteria to define polycystic ovary morphology have been established for adolescents.
In the paper
“In a study of unselected schoolgirls with oligomenorrhea, 4% had hirsutism and 57% had elevated testosterone levels [58]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [58] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Until further research establishes definitive criteria, an ovarian volume >12.0 cm 3 (by formula for a prolate ellipsoid) can be considered en-”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lack of onset of menses by age 15 years or by more than 2-3 years after thelarche regardless of chronologic age is statistically uncommon and warrants evaluation and consideration of diagnoses such as PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For these reasons, testosterone concentrations should be considered elevated when they are persistently greater than the adult female normative values according to assays performed by specialty laboratories with welldefined reference intervals.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A single androgen level >2 SD above the mean for the specific assay should not be considered to be evidence of hyperandrogenism in an otherwise asymptomatic adolescent girl (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Hence, PCOM is an inconsistent finding and does not invariably predict the development of PCOS [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Gambineri et al. [61] defined hyperandrogenism during the follicular phase as total testosterone concentrations >42 ng/dl using a LC-MS/MS assay.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [61] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“These trials have also shown improvements related to hirsutism, ovulation, quality of life, sleep, lipid profile, adipocytokine levels, and insulin resistance [148-160]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A diagnosis of PCOS can impact an adolescent's quality of life; this diagnosis can create early and unwarranted anxiety about future fertility for the young women and her family.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“PCOS is a common heterogeneous phenotype with features overlapping some features characteristic of normal pubertal development.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Summary
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Longer duration trials (12 months or more) are very limited and are either open-labelled trials or lack placebocontrolled arms [133, 135, 161-163]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
No consensus exists on the clinical criteria for diagnosing androgen excess in adolescence.
“No consensus exists on the clinical criteria to reach the diagnosis of androgen excess in adolescence.”
The paper relies on this without support.
The definition of persistent oligomenorrhea is uncertain.
“However, the definition of 'persistent oligomenorrhea' is uncertain.”
The paper relies on this without support.
Detailed data are not available regarding the accuracy of predicting ongoing hyperandrogenic anovulation from a single elevated testosterone level.
“However, detailed data are not available regarding the accuracy of the prediction of ongoing hyperandrogenic anovulation from a single elevated testosterone level.”
The paper relies on this without support.
No data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of polycystic ovary syndrome in adulthood.
“Further, no data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of PCOS in adulthood.”
The paper relies on this without support.
No compelling criteria to define polycystic ovary morphology have been established for adolescents.
“No compelling criteria to define PCOM have been established for adolescents.”
The paper relies on this without support.
Available data are inconsistent regarding the usefulness of anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome among adolescent girls.
“Available data are inconsistent regarding the usefulness of AMH in the diagnosis of PCOS among adolescent girls [92][93][94][95][96]”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Often each clinical symptom and comorbidity is treated separately, which can delay or obscure a diagnosis of PCOS and limit follow up care [3, 22, 23].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“These similarities between normal pubertal development and the clinical features associated with PCOS confound the diagnosis in adolescent girls (Table 1) [125–127].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
In the citing paper
“However, delineating appropriate diagnostic criteria for PCOS among adolescent girls has been problematic because irregular menses, cystic acne, mild hyperandrogenism, and multifollicular ovarian morphology occur during normal pubertal maturation.”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationDabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702
Age at menarche and racial comparisons in US girls
Chumlea, W. C., Schubert, C. M., Roche, A. F., Kulin, H. E., Lee, P. A., Himes, J. H., & Sun, S. S. (2003) · PEDIATRICS · doi:10.1542/peds.111.1.110 · Cited by 685
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Heritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647
Silverman, B. L., Metzger, B. E., Cho, N. H., & Loeb, C. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.5.611 · Cited by 643
Genotyping steroid 21-hydroxylase deficiency: hormonal reference data
NEW, M. I., LORENZEN, F., LERNER, A. J., KOHN, B., OBERFIELD, S. E., POLLACK, M. S., DUPONT, B., STONER, E., LEVY, D. J., PANG, S., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-320 · Cited by 624
Self-citationDewailly, D., Lujan, M. E., Carmina, E., Cedars, M. I., Laven, J., Norman, R. J., & Escobar-Morreale, H. F. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt061 · Cited by 551
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539
Developmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Self-citationGungor, N., Saad, R., Janosky, J., & Arslanian, S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.09.045 · Cited by 457
Self-citationPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Hagen, C. P., Aksglaede, L., Sørensen, K., Main, K. M., Boas, M., Cleemann, L., Holm, K., Gravholt, C. H., Andersson, A.-M., Pedersen, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0930 · Cited by 383
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Screening for Abnormal Glucose Tolerance in Adolescents with Polycystic Ovary Syndrome
Palmert, M. R., Gordon, C. M., Kartashov, A. I., Legro, R. S., Emans, S. J., & Dunaif, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8305 · Cited by 354
Longitudinal study of physiologic insulin resistance and metabolic changes of puberty
Hannon, T. S., Janosky, J., & Arslanian, S. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000246097.73031.27 · Cited by 353
Self-citationAnti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Carlsson, I. B. (2006) · Human Reproduction · doi:10.1093/humrep/del165 · Cited by 294
Lifestyle changes in women with polycystic ovary syndrome
Moran, L. J., Hutchison, S. K., Norman, R. J., & Teede, H. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub3 · Cited by 292
Identifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288
Self-citationDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285
Arslanian, S. A., Lewy, V., Danadian, K., & Saad, R. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8398 · Cited by 272
Self-citationSir-Petermann, T., Codner, E., Pérez, V., Echiburú, B., Maliqueo, M., Ladrón de Guevara, A., Preisler, J., Crisosto, N., Sánchez, F., Cassorla, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2836 · Cited by 260
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250
Toward Excellence in Testosterone Testing: A Consensus Statement
Rosner, W., & Vesper, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1314 · Cited by 248
Azziz, R., Hincapie, L. A., Knochenhauer, E. S., Dewailly, D., Fox, L., & Boots, L. R. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00383-0 · Cited by 244
Endocrine characteristics of adolescent menstrual cycles: impact of early menarche
Vihko, R., & Apter, D. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90209-7 · Cited by 227
Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
Guastella, E., Longo, R. A., & Carmina, E. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.02.014 · Cited by 205
Charmandari, E., Kino, T., Ichijo, T., & Chrousos, G. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0040 · Cited by 201
Ibáñez, L., Potau, N., Zampolli, M., RiquÉ, S., Saenger, P., & Carrascosa, A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4084 · Cited by 199
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192
Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155
Rapid Maturation of the Reproductive Axis during Perimenarche Independent of Body Composition1
Legro, R. S., Lin, H. M., Demers, L. M., & Lloyd, T. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6423 · Cited by 154
Palomba, S., Marotta, R., Di Cello, A., Russo, T., Falbo, A., Orio, F., Tolino, A., Zullo, F., Esposito, R., & Sala, G. B. L. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04443.x · Cited by 144
Menstrual patterns in adolescent Swiss girls: a longitudinal study
Flug, D., Largo, R. H., & Prader, A. (1984) · Annals of Human Biology · doi:10.1080/03014468400007411 · Cited by 140
Ibanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138
Ibáñez, L., López-Bermejo, A., Díaz, M., Marcos, M. V., & de Zegher, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0555 · Cited by 123
Self-citationPall, M., Azziz, R., Beires, J., & Pignatelli, D. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.06.025 · Cited by 123
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
Leibel, N. I., Baumann, E. E., Kocherginsky, M., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1707 · Cited by 118
Self-citationMcCartney, C. R., Prendergast, K. A., Blank, S. K., Helm, K. D., Chhabra, S., & Marshall, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1252 · Cited by 116
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
Ibáñez, L., Díaz, R., López-Bermejo, A., & Marcos, M. V. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9096-y · Cited by 106
Self-citationLee, S., Gungor, N., Bacha, F., & Arslanian, S. (2007) · Diabetes Care · doi:10.2337/dc07-0203 · Cited by 105
Self-citationRofey, D. L., Szigethy, E. M., Noll, R. B., Dahl, R. E., lobst, E., & Arslanian, S. A. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn057 · Cited by 104
Self-citationPolycystic Ovary Syndrome in Adolescence
Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97
Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome
Cattrall, F. R., Vollenhoven, B. J., & Weston, G. C. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.05.061 · Cited by 88
Prospective follow‐up of menstrual disorders in adolescence and prognostic factors
WIKSTEN‐ALMSTRÖMER, M., HIRSCHBERG, A. L., & HAGENFELDT, K. (2008) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1080/00016340802478166 · Cited by 80
Rosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Self-citationMenstrual Irregularities in Adolescents: Hormonal Pattern and Ovarian Morphology
Venturoli, S., Porcu, E., Fabbri, R., Paradisi, R., Ruggeri, S., Bolelli, G., Orsini, L. F., Gabbi, D., & Flamigni, C. (2008) · Hormone Research · doi:10.1159/000180567 · Cited by 69
Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood
Abbott, D. H., & Bacha, F. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.05.023 · Cited by 67
Steroid Assays and Endocrinology: Best Practices for Basic Scientists
Auchus, R. J. (2014) · Endocrinology · doi:10.1210/en.2014-7534 · Cited by 67
Li, R., Qiao, J., Yang, D., Li, S., Lu, S., Wu, X., & Wei, Z. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.03.023 · Cited by 59
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Lee, P. A., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.048 · Cited by 56
Self-citationLittlejohn, E. E., Weiss, R. E., Deplewski, D., Edidin, D. V., & Rosenfield, R. (2007) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2007.20.1.41 · Cited by 55
Self-citationBrown, M., Park, A. S., Shayya, R. F., Wolfson, T., Su, H. I., & Chang, R. J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23992 · Cited by 54
Adolescent menstrual characteristics as predictors of gynaecological health
Gardner, J. (1983) · Annals of Human Biology · doi:10.1080/03014468300006161 · Cited by 46
Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?
Dokras, A., & Witchel, S. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4190 · Cited by 43
Self-citationChen, Y., Yang, D., Li, L., & Chen, X. (2008) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2008.01.081 · Cited by 34
Díaz, M., Chacón, M. R., López-Bermejo, A., Maymó-Masip, E., Salvador, C., Vendrell, J., de Zegher, F., & Ibáñez, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1754 · Cited by 21
Self-citation
Flagged first, then by citations
Research works printed but not linked: 110
- 10.1016/j.fertnstert.2011.09.024 · DOI · Paper page
- 10.1210/jc.2005-1457 · DOI · Paper page
- 10.1038/ijo.2008.61 · DOI
- 10.1210/me.13.6.946 · DOI · Paper page
- 10.1038/nrendo.2014.58 · DOI · Paper page
- 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
- 10.1016/j.fertnstert.2008.06.035 · DOI · Paper page
- 10.1111/j.1365-2265.2007.02764.x · DOI · Paper page
- 10.1093/humrep/der418 · DOI · Paper page
- 10.1016/j.ajog.2010.03.008 · DOI · Paper page
- 10.1210/jc.2013-2350 · DOI · Paper page
- 10.1210/jc.2006-0178 · DOI · Paper page
- 10.1136/qhc.12.1.18 · DOI · Paper page
- 10.1210/er.21.4.363 · DOI
- 10.1210/jc.2007-2437 · DOI
- 10.1590/S0004-27302011000800013 · DOI · Paper page
- 10.1093/humupd/dmp024 · DOI · Paper page
- 10.3109/09513590.2013.797399 · DOI
- 10.4161/derm.1.2.8354 · DOI · Paper page
- 10.1016/j.jpag.2009.03.007 · DOI
- 10.1016/j.ajog.2004.06.064 · DOI
- 10.1016/j.fertnstert.2009.02.056 · DOI
- 10.1111/j.1524-4725.2012.02462.x · DOI
- 10.1001/archderm.135.6.656 · DOI
- 10.1016/j.fertnstert.2011.06.040 · DOI
- 10.1210/jc.2004-2301 · DOI
- 10.1016/j.bpobgyn.2004.05.007 · DOI
- 10.1136/jfprhc-2011-100175 · DOI
- 10.1067/mpd.2001.109790 · DOI
- 10.1210/jcem-21-11-1440 · DOI
- 10.1016/S0022-3476(97)70307-X · DOI
- 10.1542/peds.2013-0490B · DOI
- 10.1210/jc.2010-1123 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.056 · DOI
- 10.1210/jc.84.10.3666 · DOI · Paper page
- 10.1210/jc.2013-3399 · DOI
- 10.1016/S0022-3476(83)80678-7 · DOI
- 10.1210/jcem.85.4.6543 · DOI
- 10.1210/jc.2008-2771 · DOI
- 10.1210/jc.2013-1770 · DOI
- 10.1210/jcem-45-5-1039 · DOI
- 10.1093/humrep/14.9.2223 · DOI
- 10.1210/jcem-71-4-970 · DOI
- 10.1203/00006450-199512000-00024 · DOI
- 10.1210/jc.2012-3537 · DOI
- 10.1677/joe.0.0970213 · DOI
- 10.1016/S1043-2760(98)00020-4 · DOI · Paper page
- 10.1210/jc.2007-1846 · DOI · Paper page
- 10.1093/humrep/deh079 · DOI · Paper page
- 10.1097/00006254-196608000-00009 · DOI
- 10.1136/adc.44.235.291 · DOI · Paper page
- 10.1542/peds.2006-2481 · DOI · Paper page
- 10.1016/S0197-0070(86)80014-6 · DOI
- 10.1053/beem.2002.0203 · DOI · Paper page
- 10.1093/humrep/der102 · DOI
- 10.1016/S0140-6736(85)92552-8 · DOI
- 10.1016/j.fertnstert.2010.06.015 · DOI · Paper page
- 10.1515/jpem-2012-0014 · DOI
- 10.1210/jc.2014-3336 · DOI
- 10.1371/journal.pone.0071465 · DOI
- 10.1016/j.jpag.2013.11.007 · DOI · Paper page
- 10.1007/s00330-009-1643-8 · DOI
- 10.1016/j.fertnstert.2009.11.002 · DOI
- 10.1093/humrep/der223 · DOI
- 10.1093/humupd/dmt062 · DOI
- 10.1515/jpem-2012-0013 · DOI
- 10.1016/j.ejogrb.2014.06.018 · DOI
- 10.1016/j.steroids.2011.12.009 · DOI
- 10.1155/2010/625105 · DOI
- 10.1111/j.1365-2362.2011.02550.x · DOI
- 10.1080/09513590701297708 · DOI
- 10.4274/Jcrpe.835 · DOI
- 10.1210/jc.86.1.207 · DOI · Paper page
- 10.1016/j.fertnstert.2006.04.015 · DOI · Paper page
- 10.1067/mpd.2001.109603 · DOI · Paper page
- 10.1210/jcem.80.10.7559882 · DOI
- 10.1210/jcem.84.12.6341 · DOI · Paper page
- 10.1016/j.metabol.2005.11.003 · DOI · Paper page
- 10.1210/jc.2005-1666 · DOI
- 10.1210/jc.2008-1198 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.046 · DOI
- 10.1016/j.jpeds.2012.11.019 · DOI
- 10.1016/j.fertnstert.2011.03.001 · DOI
- 10.1210/jc.87.3.1017 · DOI · Paper page
- 10.1080/09513590802630146 · DOI
- 10.1210/jcem-62-5-904 · DOI
- 10.1210/edrv.18.6.0318 · DOI
- 10.1046/j.1365-2265.1999.00770.x · DOI
- 10.1210/jc.87.4.1555 · DOI · Paper page
- 10.1016/S1054-139X(01)00202-6 · DOI
- 10.1093/humrep/del185 · DOI
- 10.1210/jc.2010-2547 · DOI
- 10.1210/jc.2005-0438 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1210/jc.2003-031848 · DOI
- 10.1136/adc.2004.053959 · DOI
- 10.1210/jc.2006-2002 · DOI
- 10.1515/JPEM.2005.18.8.761 · DOI · Paper page
- 10.1001/archpedi.160.3.241 · DOI · Paper page
- 10.1210/jc.2008-0461 · DOI · Paper page
- 10.1016/j.jpag.2013.09.011 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1016/j.fertnstert.2009.08.006 · DOI · Paper page
- 10.1016/j.jpag.2014.01.004 · DOI
- 10.1111/cen.12028 · DOI
- 10.1210/jc.2003-031281 · DOI
- 10.1210/jc.2011-1609 · DOI · Paper page
- 10.1080/713603060 · DOI · Paper page
- 10.1210/jc.2013-1041 · DOI · Paper page
- 10.1016/S0015-0282(02)02993-X · DOI · Paper page
Cited by
Sorted by citations
Variations in the pattern of pubertal changes in boys
Marshall, W. A., & Tanner, J. M. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.13 · Cited by 5,147
Tanner, J. M., & Whitehouse, R. H. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.3.170 · Cited by 3,137
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Metadata
- Authors
- Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., Tfayli, H., Arslanian, S., Dabadghao, P., Garcia Rudaz, C., & Lee, P. A.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- Morgan Stanley Children's Hospital (US)
- University of Chicago (US)
- Nationwide Children's Hospital (US)
- Hospital Sant Joan de Déu Barcelona (ES)
- National Center For Child Health and Development (JP)
- Baylor College of Medicine (US)
- American University of Beirut Medical Center (LB)
- University of Pittsburgh (US)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Pennsylvania State University (US)
- ORCID
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 6
- Pages
- 376-389
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2053105417
- Cited by
- 3,113
- References
- 67
- Citations by year
- 2026: 17 · 2025: 119 · 2024: 197 · 2023: 328 · 2022: 357 · 2021: 237 · 2020: 231 · 2019: 276 · 2018: 244 · 2017: 223 · 2016: 206 · 2015: 187
- FWCI
- 43.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- National Center for Research Resources (M01RR010732)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, adolescents, diagnostic criteria, hyperandrogenism, oligoanovulation, polycystic ovary morphology, insulin resistance, hyperinsulinemia, obesity, amenorrhea, longitudinal assessment
- MeSH terms
- Adolescent, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Puberty, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
